TrialAnnals of the rheumatic diseases2006

Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.

P Sarzi-Puttini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.